Women’s perceptions with use of Implanon® contraceptive device at a primary healthcare facility in KwaZulu-Natal

Health SA Gesondheid

Field Value
Title Women’s perceptions with use of Implanon® contraceptive device at a primary healthcare facility in KwaZulu-Natal
Creator Mgobhozi, Lucky N. Mchunu, Gugu G. Mbeje, Pretty
Subject — Implanon®; contraception; perceptions; family planning; primary healthcare
Description Background: Early 2014, subdermal contraceptive implant was introduced in South Africa, Implanon® NXT, aiming to expand the method mix, increase effectiveness and availability to long-acting contraceptives. The initial uptake was extremely high, but concerns have been raised with treatment failure and high number of removals reported.Aim: The study focuses on describing women’s perceptions with use of Implanon® at a primary health care (PHC) facility in KwaZulu-Natal.Setting: This study was conducted at a selected primary health care (PHC) facility in KwaZulu-Natal.Methods: A quantitative, descriptive study design was used. Through purposive sampling, a sample of 60 women from 15 to 50 years old were recruited. Data were gathered through a structured questionnaire and analysed using SPSS 24 software.Results: Study findings show that slightly above half of respondents, 32 or 58.1% expressed satisfaction towards the implant, 20 or 40.9% had stopped using the implant as a result of its major implications. It was found that an edge above half of respondents continued using the implant 28 or 50.9%, while close to half had abandoned it (27 or 49.1%). Some respondents reported that they were experiencing heavy menstrual bleeding and low sex drive as serious unwanted side effects forcing them to stop using Implanon®.Conclusion: Side-effects and poor screening, counselling and support are major reasons for early removal. It is imperative to develop an effective screening tool and to re-train healthcare workers on Implanon® NXT.Contributions: This article contributes to increase awareness of women’s perceptions about Implanon® contraceptive.
Publisher AOSIS Publishing
Date 2023-10-20
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — quantitative approach
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/hsag.v28i0.2016
Source Health SA Gesondheid; Vol 28 (2023); 8 pages 2071-9736 1025-9848
Language eng
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://hsag.co.za/index.php/hsag/article/view/2016/html https://hsag.co.za/index.php/hsag/article/view/2016/epub https://hsag.co.za/index.php/hsag/article/view/2016/xml https://hsag.co.za/index.php/hsag/article/view/2016/pdf
Coverage KwaZulu-Natal; South Africa 2016 -2019 between 15 to 50; women; all ethnic groups
Rights Copyright (c) 2023 Lucky N. Mgobhozi, Gugu G. Mchunu, Pretty Mbeje https://creativecommons.org/licenses/by/4.0